[go: up one dir, main page]

EP0381747A4 - Water soluble branched beta cyclodextrin steroid complex - Google Patents

Water soluble branched beta cyclodextrin steroid complex

Info

Publication number
EP0381747A4
EP0381747A4 EP19890909972 EP89909972A EP0381747A4 EP 0381747 A4 EP0381747 A4 EP 0381747A4 EP 19890909972 EP19890909972 EP 19890909972 EP 89909972 A EP89909972 A EP 89909972A EP 0381747 A4 EP0381747 A4 EP 0381747A4
Authority
EP
European Patent Office
Prior art keywords
beta cyclodextrin
steroid
branched beta
branched
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19890909972
Other languages
French (fr)
Other versions
EP0381747A1 (en
Inventor
Robert N. Ammeraal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerestar USA Inc
Original Assignee
American Maize Products Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Maize Products Co filed Critical American Maize Products Co
Publication of EP0381747A1 publication Critical patent/EP0381747A1/en
Publication of EP0381747A4 publication Critical patent/EP0381747A4/en
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Definitions

  • This invention relates to a complex of branched beta cyclodextrin and steroid and the use of such a complex to make the steroid water soluble.
  • Starch occurs naturally in a variety of plants such as corn, potato, sorghum and rice and is extracted from portions of the plant by a milling operation which separates the starch from the plant. Physically the starch is in a granular form which typically comprises both amylose and amylopectin.
  • Amylose is a straight chained polymer of anhydroglucose units bonded together by alpha 1,4 bonds while amylopectin is a polymer composed of a straight chain of alpha 1,4 anhydroglucose onto which side chains of alpha 1,4 anhydroglucose polymers are bonded.
  • amylopectin the bond between the straight chain and the side chain is an alpha 1,6 bond.
  • amylose and amylopectin in a starch granule depends on the source of the starch. For example, high amylose corn starch contains about a 50:50 ratio while waxy corn starch contains about a 99:1 ratio of amylopectin to amylose.
  • Cyclodextrins also called Schardingers dextrins, cycloamyloses, cyclomaltoses and cycloglucans, are polymers of anhydroglucose polymers, bonded together by alpha 1,4 bonds to form a ringed compound.
  • a six membered ring is called alpha cyclodextrin, seven, beta cyclodextrin and eight, gamma cyclodextrin. These six, seven and eight membered rings are also referred to as cyclomaltohexaose, cyclomaltoheptaose and cyclomaltooctaose, respectively.
  • Beta cyclodextrins have one or more anhydroglucose units bonded onto the ring structure such that a branch extends out from the ring structure.
  • the branch is bonded to the ring by an alpha 1,6 bond where the branched beta cyclodextrin is obtained from an enzymatic process.
  • Steroids are typically used in aqueous media and ointments as pharmaceutical preparations for treatment of the skin and eyes. Because steroids are highly water insoluble, any aqueous medium containing steroids must be vigorously shaken before application. Steroids are classified as lipids because they are highly water insoluble and are soluble in organic solvents.
  • beta cyclodextrin be chemically modified by reacting the beta cyclodextrin with methyl groups to form dimethyl beta cyclodextrin and then form a complex with a steroid.
  • Such a chemically modified starch is not ideal for pharmaceutical use.
  • branched beta cyclodextrin where the branch length was greater than one anhydroglucose unit.
  • the complex of branched beta cyclodextrin and steroid has a solubility comparable to a complex of dimethyl-beta cyclodextrin and steroid. This is surprising because of the difference in chemical structure between the branched beta cyclodextrin and dimethyl-beta cyclodextrin. Further, it is surprising that a complex forms between branched beta cyclodextrin and a steroid because of the hydrophillic nature of the branch itself and the hydrophobic nature of steroids.
  • Branched beta cyclodextrins are conventionally prepared by treating starch slurry high in amylopectin with an enzyme, cyclodextrin glycosyltransferase (CGT), at the appropriate pH, temperature and time for the selected CGT.
  • CGT cyclodextrin glycosyltransferase
  • the starch used for this enzymatic preparation of branched beta cyclodextrin may be from any selected plant variety; however, it is preferable that the starch be high in amylopectin content.
  • the enzyme CGT is obtained from microorganisms such as Bacillus macerans, B. megaterium, B. circulans, B. stearothermophilus and Bacillus sp. (alkalophilic) as well as others.
  • the starch is slurried in aqueous solution at a concentration up to about 35% by weight solids.
  • the slurry is then subjected to gelatinization and liquefaction by enzyme or acid to about 1 to about 5 DE.
  • the preferred enzyme for liquefaction is bacterial alpha amylase.
  • the selected CGT is added to the gelatinized and liquefied slurry and the pH, temperature and time of the treatment are adjusted depending on the selected enzyme.
  • the pH is between about 4.5 to about 8.5
  • the temperature ranges between ambient to about 75°C and the length of the reaction runs for about ten hours to seven days.
  • the amount of branched beta cyclodextrin will vary depending on the treatment conditions and the starch selected.
  • the reaction between CGT and the gelatinized and liquefied starch slurry is conducted under a solvent such as toluene or p-xylene.
  • solvents substantially facilitate the isolation of branched beta cyclodextrin.
  • branched beta cyclodextrins when starch is treated with CGT, branched beta cyclodextrins, beta cyclodextrins and other dextrins are formed.
  • the branched beta cyclodextrin In order to obtain branched beta cyclodextrin, the branched beta cyclodextrin must be separated from the beta cyclodextrin and the other dextrins.
  • branched beta cyclodextrin is separated from beta cyclodextrin and other dextrins by forming a first precipitate and a first liquor from an aqueous first solution containing branched beta cyclodextrin by the addition of a beta cyclodextrin complexant to the aqueous first solution; recovering the first precipitate; forming a second aqueous solution with the first precipitate; forming a second precipitate and a second liquor from said second solution by the addition of a beta cyclodextrin complexant to said second solution; recovering the second liquor; and, finally, recovering branched beta cyclodextrin from said second liquor.
  • the aqueous starting solution is an aqueous solution containing branched and non-branched beta cyclodextrins such that about 1% or more of the total solids content of the solution is branched beta cyclodextrin and such that the non-branched beta cyclodextrin is in an amount in excess of the branched beta cyclodextrin. Invariably, some beta cyclodextrin will be present with the branched beta cyclodextrin.
  • Branched beta cyclodextrins are characterized more specifically by the length of or the number of glucose units in the branch.
  • a branched beta cyclodextrin which has a single glucose unit attached to the ringed structure is called 6-alpha-D-glucosylcyclomaltoheptaose or GlcG7
  • a branched beta cyclodextrin having two glucose units on the branch is referred to as 6-alpha-D-maltosylcyclomaltoheptaose or G2cG7
  • a branched beta cyclodextrin with three glucose units on the branch is referred to conveniently as G3cG7, four glucose units as G4cG7, and so on.
  • the branched beta cyclodextrins may also be formed by a pyrolysis method, preferably as taught by the co-pending U.S. application filed concurrently herewith.
  • Such branched beta cyclodextrins have branches of anhydroglucose units which are bonded to the ring structure of the beta cyclodextrin by bonds other than a 1,6 bond.
  • Branched beta cyclodextrin can also be formed by enzymatic techniques where anhydroglucose units are added onto the cyclodextrin ring, see for example U.S. Patent No. 4,668,626 issued May 26, 1987.
  • branched beta cyclodextrin as used in the specification and claims means branched beta cyclodextrin obtained from enzyme or pyrolysis.
  • the branch length of the branched beta cyclodextrins used in the present invention is between about 1 to about 7 glucose units, i.e. GlcG7 to G7cG7. Good results have been obtained with GlcG7 to G3cG7. It is thought that a complex forms between the steroid and the branched beta cyclodextrin where the steroid is a guest molecule inside the cavity of the branched beta cyclodextrin, which is acting as a host molecule.
  • Steroids which are suitable for complexing with branched beta cyclodextrins have a molecular structure which allows at least a portion of the steroid's molecular structure to be housed inside the cavity of the branched beta cyclodextrin.
  • Suitable steroids include corticosteroids such as dexamethasone, prednisolone and hydrocortisone; androgens; anabolic steroids; estrogens; and progestagens. Good results have been obtained with hydrocortisone, progesterone and testosterone.
  • an aqueous mixture of steroid and branched beta cyclodextrin is prepared and gently mixed at ambient conditions.
  • the ratio of branched beta cyclodextrin to steroid is about 1:1; however, in order to complex as much of the steroid as possible, preferably an excess of branched beta cyclodextrin is added to the solution.
  • the stoichiometric ratio of branched beta cyclodextrin to steroid is about 2:1, but this will vary with the individual steroid.
  • an aqueous solution of branched beta cyclodextrin is prepared such that the solution has a solids concentration of between about 10 to about 50% branched beta cyclodextrin based on the total weight of solution. Good results have been obtained when the aqueous solution of branched beta cyclodextrin has a solids concentration of about 14% by weight.
  • This mixing is preferably carried out at ambient conditions. In order to prepare this solution, mixing can be employed. To this aqueous solution of branched beta cyclodextrin a steroid is added in the appropriate amount. The overall mixture of water, branched beta cyclodextrin and steroid is then gently mixed by conventional means while maintaining the mixture at ambient conditions. The mixing proceeds until an equilibrium is obtained, preferably for about 4 to about 24 hours. The complex of branched beta cyclodextrin and steroid is then obtained from the aqueous solution in a conventional manner, typically by evaporation.
  • the complex is left in solution and merely concentrated or evaporated to the appropriate concentration for use.
  • Crystals of GlcG7 and hydrocortisone may be obtained by concentration to about
  • This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 1. To this solution was added the hydrocortisone in the amounts shown in Table 1 below. The mixture was stirred for about 4 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 1 below further illustrates this example. TABLE 1
  • hydrocortisone was a commercially available hydrocortisone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
  • Total Weight Hydrocortisone Branched beta cyclodextrin 1.008 Total Weight Hydrocortisone : Beta cyclodextrin
  • the hydrocortisone was a commercially available hydrocortisone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • the solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml.
  • the observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 21.4 mg/ml under ambient conditions
  • the solubility of the steroid has been increased by a factor of 59.
  • This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is progesterone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
  • Free branched beta cyclodextrin added 1.202 Free branched beta cyclodextrin after complexation .677
  • the progesterone was a commercially available progesterone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added.
  • the amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is testosterone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 4. To this solution was added the testosterone in the amounts shown in Table 4 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved testosterone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free testosterone. This example was run at ambient conditions.
  • the testosterone was a commercially available testosterone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • the solubility of testosterone in water under ambient conditions has been reported as 0.040 mg/ml.
  • the observed solubility in water of the branched beta cyclodextrin and testosterone complex in this example after concentration was 39.8 mg/ml under ambient conditions.
  • the solubility of the steroid has been increased by a factor of 995.
  • Example 5 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 5. To this solution was added the hydrocortisone in the amounts shown in Table 5 below. The mixture was stirred for about 21 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 5 below further illustrates this example.
  • the branched beta cyclodextrin was isolated from pyrolyzed branched beta cyclodextrin by solvent precipitation and chromatographic separation.
  • the hydrocortisone was a commercially available hydrocortisone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated. The solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml.
  • Example 6 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 6. To this solution was added the hydrocortisone in the amounts shown in Table 6 below. The mixture was stirred for about 4 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 6 below further illustrates this example.
  • the hydrocortisone was a commercially available hydrocortisone having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • the solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml.
  • the observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 53.6 mg/ml under ambient conditions,
  • the solubility of the steroid has been increased by a factor of 149.
  • Example 7 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is cholesterol.
  • a solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
  • Table 7 To this solution was added the cholesterol in the amounts shown in Table 7 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved cholesterol. The filtrate contained the complex, the free branched beta cyclodextrin and trace free cholesterol. This example was run at ambient conditions. Table 7 below further illustrates this example. TABLE 7
  • the cholesterol was a commercially available cholesterol having a high purity.
  • the amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
  • the branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate.
  • the beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
  • the solubility of cholesterol in water under ambient conditions has been reported as 0.002 mg/ml.
  • the observed solubility in water of the branched beta cyclodextrin and cholesterol complex in this example was 3.7 mg/ml under ambient conditions.
  • the solubility of the steroid has been increased by a factor of 1838.
  • This example compares the solubility of the branched beta cyclodextrin-steroid complex of the present invention against like steroids complexed with gamma cyclodextrin, alpha cyclodextrin, beta cyclodextrin, and dimethyl beta cyclodextrin.
  • the gamma, alpha, and dimethyl beta cyclodextrin complexes were prepared under ambient conditions with cyclodextrins at a concentration of 0.075 M. Because of the low solubility of beta cyclodextrin, the concentration of this solution was 0.0112 M in water under ambient conditions.
  • Table 8 Table 8
  • Methyltestosterone (a) Testosterone (b) Progesterone Hydrocortisone
  • the present invention produces superior results compared to the gamma and beta cyclodextrin and comparable results to dimethyl beta cyclodextrin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)

Abstract

A complex of branched beta cyclodextrin and steroid is formed by mixing a steroid and a branched beta cyclodextrin together in water for a period of about 4 to 24 hours under ambient conditions. The solubility of the steroid is increased about 95 times by employing the complex.

Description

WATER SOLUBLE BRANCHED BETA CYCLODEXTRIN STEROID COMPLEX
This invention relates to a complex of branched beta cyclodextrin and steroid and the use of such a complex to make the steroid water soluble.
Starch occurs naturally in a variety of plants such as corn, potato, sorghum and rice and is extracted from portions of the plant by a milling operation which separates the starch from the plant. Physically the starch is in a granular form which typically comprises both amylose and amylopectin. Amylose is a straight chained polymer of anhydroglucose units bonded together by alpha 1,4 bonds while amylopectin is a polymer composed of a straight chain of alpha 1,4 anhydroglucose onto which side chains of alpha 1,4 anhydroglucose polymers are bonded. In amylopectin, the bond between the straight chain and the side chain is an alpha 1,6 bond. The amount of amylose and amylopectin in a starch granule depends on the source of the starch. For example, high amylose corn starch contains about a 50:50 ratio while waxy corn starch contains about a 99:1 ratio of amylopectin to amylose.
Cyclodextrins, also called Schardingers dextrins, cycloamyloses, cyclomaltoses and cycloglucans, are polymers of anhydroglucose polymers, bonded together by alpha 1,4 bonds to form a ringed compound. A six membered ring is called alpha cyclodextrin, seven, beta cyclodextrin and eight, gamma cyclodextrin. These six, seven and eight membered rings are also referred to as cyclomaltohexaose, cyclomaltoheptaose and cyclomaltooctaose, respectively.
Branched cyclodextrins were described as early as
1965 by French and his co-workers, see French et al.,
"Archives of Biochem. and Biophys.", Volume III, 1965, pages 153-150, but had been studied very little until recently. Branched beta cyclodextrins, as their name implies, have one or more anhydroglucose units bonded onto the ring structure such that a branch extends out from the ring structure. The branch is bonded to the ring by an alpha 1,6 bond where the branched beta cyclodextrin is obtained from an enzymatic process.
Steroids are typically used in aqueous media and ointments as pharmaceutical preparations for treatment of the skin and eyes. Because steroids are highly water insoluble, any aqueous medium containing steroids must be vigorously shaken before application. Steroids are classified as lipids because they are highly water insoluble and are soluble in organic solvents.
In order to increase the water solubility of the steroid, it has been suggested in U.S. Patent No. 4,383,992 issued May 17, 1983 that a complex of beta cyclodextrin and steroid be formed. It is alleged that such a complex is water soluble. Typically, a complex of a steroid and unsubstituted beta cyclodextrin contains less than about ½% soluble steroid at ambient conditions. It has also been suggested that in order to increase the water solubility of a steroid a complex of alpha or gamma cyclodextrin and steroid be formed. Under ambient conditions, the alpha cyclodextrin-steroid solution typically contains less than about 1% soluble steroid and the gamma cyclodextrin-steroid solution also typically contains less than about 1% soluble steroid.
It has further been suggested that the beta cyclodextrin be chemically modified by reacting the beta cyclodextrin with methyl groups to form dimethyl beta cyclodextrin and then form a complex with a steroid. Such a chemically modified starch is not ideal for pharmaceutical use.
It has now been discovered that branched beta cyclodextrin will form a complex with a steroid and that such a complex is highly water soluble. In fact, it has been found that such a complex may have a solubility up to about 2800 times greater than that of the steroid itself and about 100 times greater than that of the complex of beta cyclodextrin and steroid. These results are surprising because there had been speculation that the branch of anhydroglucose might interfere with or in some way react with the steroid itself and thus inhibit the complexation phenomenon between the steroid and the cavity of branched beta cyclodextrin. This is especially true for branched beta cyclodextrin where the branch length was greater than one anhydroglucose unit. Additionally, it is surprising that the complex of branched beta cyclodextrin and steroid has a solubility comparable to a complex of dimethyl-beta cyclodextrin and steroid. This is surprising because of the difference in chemical structure between the branched beta cyclodextrin and dimethyl-beta cyclodextrin. Further, it is surprising that a complex forms between branched beta cyclodextrin and a steroid because of the hydrophillic nature of the branch itself and the hydrophobic nature of steroids.
Further, it is surprising that crystals of branched beta cyclodextrin and steroid were formed where the branch is one anhydroglucose unit because branched beta cyclodextrin having a branch of one anhydroglucose unit does not form a crystalline structure alone.
Branched beta cyclodextrins are conventionally prepared by treating starch slurry high in amylopectin with an enzyme, cyclodextrin glycosyltransferase (CGT), at the appropriate pH, temperature and time for the selected CGT. The starch used for this enzymatic preparation of branched beta cyclodextrin may be from any selected plant variety; however, it is preferable that the starch be high in amylopectin content. The enzyme CGT is obtained from microorganisms such as Bacillus macerans, B. megaterium, B. circulans, B. stearothermophilus and Bacillus sp. (alkalophilic) as well as others. Conventionally, the starch is slurried in aqueous solution at a concentration up to about 35% by weight solids. The slurry is then subjected to gelatinization and liquefaction by enzyme or acid to about 1 to about 5 DE. The preferred enzyme for liquefaction is bacterial alpha amylase. After deactivating the liquefying enzyme, the selected CGT is added to the gelatinized and liquefied slurry and the pH, temperature and time of the treatment are adjusted depending on the selected enzyme. Generally, the pH is between about 4.5 to about 8.5, the temperature ranges between ambient to about 75°C and the length of the reaction runs for about ten hours to seven days. The amount of branched beta cyclodextrin will vary depending on the treatment conditions and the starch selected. In order to produce predominantly beta cyclodextrin and branched beta cyclodextrin, the reaction between CGT and the gelatinized and liquefied starch slurry is conducted under a solvent such as toluene or p-xylene. Such solvents substantially facilitate the isolation of branched beta cyclodextrin.
Normally, when starch is treated with CGT, branched beta cyclodextrins, beta cyclodextrins and other dextrins are formed. In order to obtain branched beta cyclodextrin, the branched beta cyclodextrin must be separated from the beta cyclodextrin and the other dextrins.
The purification and separation of branched beta cyclodextrin can be successfully accomplished by employing the method taught in co-pending application Serial No. 071,097 filed July 8, 1987, which is incorporated by reference herein. As taught by that reference, branched beta cyclodextrin is separated from beta cyclodextrin and other dextrins by forming a first precipitate and a first liquor from an aqueous first solution containing branched beta cyclodextrin by the addition of a beta cyclodextrin complexant to the aqueous first solution; recovering the first precipitate; forming a second aqueous solution with the first precipitate; forming a second precipitate and a second liquor from said second solution by the addition of a beta cyclodextrin complexant to said second solution; recovering the second liquor; and, finally, recovering branched beta cyclodextrin from said second liquor. The aqueous starting solution is an aqueous solution containing branched and non-branched beta cyclodextrins such that about 1% or more of the total solids content of the solution is branched beta cyclodextrin and such that the non-branched beta cyclodextrin is in an amount in excess of the branched beta cyclodextrin. Invariably, some beta cyclodextrin will be present with the branched beta cyclodextrin.
Branched beta cyclodextrins are characterized more specifically by the length of or the number of glucose units in the branch. For example, a branched beta cyclodextrin which has a single glucose unit attached to the ringed structure is called 6-alpha-D-glucosylcyclomaltoheptaose or GlcG7 , a branched beta cyclodextrin having two glucose units on the branch is referred to as 6-alpha-D-maltosylcyclomaltoheptaose or G2cG7. A branched beta cyclodextrin with three glucose units on the branch is referred to conveniently as G3cG7, four glucose units as G4cG7, and so on.
The branched beta cyclodextrins may also be formed by a pyrolysis method, preferably as taught by the co-pending U.S. application filed concurrently herewith. Such branched beta cyclodextrins have branches of anhydroglucose units which are bonded to the ring structure of the beta cyclodextrin by bonds other than a 1,6 bond. Branched beta cyclodextrin can also be formed by enzymatic techniques where anhydroglucose units are added onto the cyclodextrin ring, see for example U.S. Patent No. 4,668,626 issued May 26, 1987. The term "branched beta cyclodextrin" as used in the specification and claims means branched beta cyclodextrin obtained from enzyme or pyrolysis. Preferably, the branch length of the branched beta cyclodextrins used in the present invention is between about 1 to about 7 glucose units, i.e. GlcG7 to G7cG7. Good results have been obtained with GlcG7 to G3cG7. It is thought that a complex forms between the steroid and the branched beta cyclodextrin where the steroid is a guest molecule inside the cavity of the branched beta cyclodextrin, which is acting as a host molecule. It is thought that not all of the steroid can physically fit inside the cavity of the branched beta cyclodextrin but that a portion of the polycyclic ring structure fits therein. Upon complexing with the branched beta cyclodextrin, the steroid, which is typically water insoluble, becomes highly water soluble.
Steroids which are suitable for complexing with branched beta cyclodextrins have a molecular structure which allows at least a portion of the steroid's molecular structure to be housed inside the cavity of the branched beta cyclodextrin. Suitable steroids include corticosteroids such as dexamethasone, prednisolone and hydrocortisone; androgens; anabolic steroids; estrogens; and progestagens. Good results have been obtained with hydrocortisone, progesterone and testosterone.
In order to form the complex between the branched beta cyclodextrin and the steroid, an aqueous mixture of steroid and branched beta cyclodextrin is prepared and gently mixed at ambient conditions. Stoichiometrically, the ratio of branched beta cyclodextrin to steroid is about 1:1; however, in order to complex as much of the steroid as possible, preferably an excess of branched beta cyclodextrin is added to the solution. Most preferably, the stoichiometric ratio of branched beta cyclodextrin to steroid is about 2:1, but this will vary with the individual steroid.
Preferably, first an aqueous solution of branched beta cyclodextrin is prepared such that the solution has a solids concentration of between about 10 to about 50% branched beta cyclodextrin based on the total weight of solution. Good results have been obtained when the aqueous solution of branched beta cyclodextrin has a solids concentration of about 14% by weight. This mixing is preferably carried out at ambient conditions. In order to prepare this solution, mixing can be employed. To this aqueous solution of branched beta cyclodextrin a steroid is added in the appropriate amount. The overall mixture of water, branched beta cyclodextrin and steroid is then gently mixed by conventional means while maintaining the mixture at ambient conditions. The mixing proceeds until an equilibrium is obtained, preferably for about 4 to about 24 hours. The complex of branched beta cyclodextrin and steroid is then obtained from the aqueous solution in a conventional manner, typically by evaporation.
Alternatively, the complex is left in solution and merely concentrated or evaporated to the appropriate concentration for use. Crystals of GlcG7 and hydrocortisone may be obtained by concentration to about
30% solids. Upon cooling and standing at 30% solids the complex crystallizes from solution. The material obtained from drying is an equilibrium mixture of complex, free branched beta cyclodextrin and a trace of free steroid. If crystals are obtained, as is the case with
GlcG7 and hydrocortisone, subsequent solutions of the crystalline complex in water may result in precipitation of free steroid unless an appropriate amount of free branched beta cyclodextrin is present. Incorporation of the steroid-branched beta cyclodextrin complex in a pharmaceutical preparation is accomplished in a conventional manner. However, because of the increased solubility of the complex, the steroid can more readily be incorporated into a pharmaceutical preparation.
These and other aspects of the present invention may be more fully understood by reference to the following examples.
Example 1
This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 1. To this solution was added the hydrocortisone in the amounts shown in Table 1 below. The mixture was stirred for about 4 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 1 below further illustrates this example. TABLE 1
Element Amount (gm)
Carbohydrate added 1.390
Free branched beta cyclodextrin added 1.307 Free branched beta cyclodextrin after complexation .413
Complexed branched beta cyclodextrin .916 Average molecular weight of branched beta cyclodextrin 1328
Average DP of branch 1.19
Hydrocortisone complexed in branched beta cyclodextrin .250
Free beta cyclodextrin added (impurity) .083
Free beta cyclodextrin after complexation .025 Complexed beta cyclodextrin .058
Hydrocortisone complexed in beta cyclodextrin .019
Free hydrocortisone added .400
Free soluble hydrocortisone after complexation .002
Insoluble hydrocortisone after complexation .129
Complexation hydrocortisone (.271 - 002) = .269
S/S0 (S= 271 = 28.65; S0 = .36 mg/ml ) 79.57 9.46
Water 8.54 ml
Solution 9.46 ml
Total Weight of Complex 1.243
Total Weight Hydrocortisone:Branched beta cyclodextrin 1.166 Table 1 (continued)
Total Weight Hydrocortisone : Beta cyclodextrin .077
Efficiency (assume 1:1 complex) .916/1.307 = .7008 The hydrocortisone was a commercially available hydrocortisone having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
The solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml.
The observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 65.0 mg/ml under ambient conditions, By employing the present invention the solubility of the steroid has been increased by a factor of 181.
Example 2
This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
Table 2. To this solution was added the hydrocortisone in the amounts shown in Table 2 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 2 below further illustrates this example. TABLE 2
Element Amount (gm)
Carbohydrate added 1.400
Free branched beta cyclodextrin added 1.202
Free branched beta cyclodextrin after complexation .361 Table 2 (continued)
Complexed branched beta cyclodextrin .841
Average molecular weight of branched beta cyclodextrin 1828 Average DP of branch 4.27
Hydrocortisone complexed in branched beta cyclodextrin .167
Free beta cyclodextrin added (impurity) --
Free beta cyclodextrin after complexation -- Complexed beta cyclodextrin --
Hydrocortisone complexed in beta cyclodextrin --
Free hydrocortisone added .2986
Free soluble hydrocortisone after complexation .0031
Insoluble hydrocortisone after complexation .1286
Complexation hydrocortisone ( .1700-.0031 ) = .1669
S/S0 (S= 170 = 17.86; S0 = .36 mg/ml ) 49.60 9.52 Water 8.6 ml
Solution 9.52 ml
Total Weight of Complex 1.008
Total Weight Hydrocortisone:Branched beta cyclodextrin 1.008 Total Weight Hydrocortisone : Beta cyclodextrin The hydrocortisone was a commercially available hydrocortisone having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated. The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated. The solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml. The observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 21.4 mg/ml under ambient conditions By employing the present invention the solubility of the steroid has been increased by a factor of 59. Example 3
This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is progesterone. A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
Table 3. To this solution was added the progesterone in the amounts shown in Table 3 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved progesterone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free progesterone. This example was run at ambient conditions. Table 3 below further illustrates this example.
TABLE 3
Element Amount ( gm )
Carbohydrate added 1.400
Free branched beta cyclodextrin added 1.202 Free branched beta cyclodextrin after complexation .677
Complexed branched beta cyclodextrin .525
Average molecular weight of branched beta cyclodextrin 1828 Average DP of branch 4.27 Table 3 ( continued)
Progesterone complexed in branched beta cyclodextrin .0904
Free beta cyclodextrin added (impurity) -- Free beta cyclodextrin after complexation --
Complexed beta cyclodextrin --
Progesterone complexed in beta cyclodextrin --
Free progesterone added .3000 Free soluble progesterone after complexation .00014
Insoluble progesterone after complexation .2095
Complexation progesterone (.0905-.0001) = .0904
S/S0 (S= 90.4 = 9.50; SQ= .016 mg/ml ) 593.5 9.52 Water 8.6 ml
Solution 9.52 ml
Total Weight of Complex .615
Total Weight Progesterone:Branched beta cyclodextrin .615 Total Weight Progesterone:Beta cyclodextrin --
Efficiency (complexed/total branched beta cyclodextrin) .437
The progesterone was a commercially available progesterone having a high purity. The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
The solubility of progesterone in water under ambient conditions has been reported as 0.016 mg/ml. The observed solubility in water of the branched beta cyclodextrin and progesterone complex in this example after concentration was 44.8 mg/ml under ambient conditions By employing the present invention the solubility of the steroid has been increased by a factor of 2800. Example 4
This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is testosterone. A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 4. To this solution was added the testosterone in the amounts shown in Table 4 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved testosterone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free testosterone. This example was run at ambient conditions.
Table 4 below further illustrates this example. TABLE 4
Element Amount ( gm )
Carbohydrate added 1 . 400
Free branched beta cyclodextrin added 1 . 202
Free branched beta cyclodextrin after complexation .644
Complexed branched beta cyclodextrin . 558
Average molecular weight of branched beta cyclodextrin 1828
Average DP of branch 4 . 27 Testosterone complexed in branched beta cyclodextrin .088
Free beta cyclodextrin added (impurity) Table 4 (continued)
Free beta cyclodextrin after complexation --
Complexed beta cyclodextrin --
Testosterone complexed in beta cyclodextrin --
Free testosterone added .303
Free soluble testosterone after complexation .00034
Insoluble testosterone after complexation .215
Complexation testosterone (.088-.000) = .088 S/S0 (S= 88 = 9.24; S0 = .040 mg/ml) 231.1
9.52
Water 8.6 ml
Solution 9.52 ml
Total Weight of Complex .646 Total Weight Testosterone :Branched beta cyclodextrin .646
Total Weight Testosterone: Beta cyclodextrin
Efficiency Complexed: Total Branched beta cyclodextrin .464
The testosterone was a commercially available testosterone having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated. The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated. The solubility of testosterone in water under ambient conditions has been reported as 0.040 mg/ml. The observed solubility in water of the branched beta cyclodextrin and testosterone complex in this example after concentration was 39.8 mg/ml under ambient conditions. By employing the present invention the solubility of the steroid has been increased by a factor of 995.
Example 5 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 5. To this solution was added the hydrocortisone in the amounts shown in Table 5 below. The mixture was stirred for about 21 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 5 below further illustrates this example.
TABLE 5
Element Amount ( gm ) Carbohydrate added 1.970
Free branched beta cyclodextrin added 1.604
Free branched beta cyclodextrin after complexation .481
Complexed branched beta cyclodextrin 1.123 Average molecular weight of branched beta cyclodextrin 1867
Average DP of branch* 4.52
Hydrocortisone complexed in branched beta cyclodextrin .218 Free beta cyclodextrin added (impurity) .090
Free beta cyclodextrin after complexation .023
Complexed beta cyclodextrin .071 Table 5 (continued)
Hydrocortisone complexed in beta cyclodextrin .023
Free hydrocortisone added .545 Free soluble hydrocortisone after complexation .0044
Insoluble hydrocortisone after complexation .299
Complexation hydrocortisone (.246-.004) = .242
S/S0 (S= 246 = 18.36; S0 = .36 mg/ml ) 51.00 13.40
Water 12.101 ml
Solution 13.40 ml
Total Weight of Complex 1.435
Total Weight Hydrocortisone:Branched beta cyclodextrin 1.341
Total Weight Hydrocortisone:Beta cyclodextrin .094
The branched beta cyclodextrin was isolated from pyrolyzed branched beta cyclodextrin by solvent precipitation and chromatographic separation.
The hydrocortisone was a commercially available hydrocortisone having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated. The solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml. The observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 87.1 mg/ml under ambient conditions By employing the present invention the solubility of the steroid has been increased by a factor of 242.
Example 6 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is hydrocortisone.
A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in Table 6. To this solution was added the hydrocortisone in the amounts shown in Table 6 below. The mixture was stirred for about 4 hours and then filtered to remove undissolved hydrocortisone. The filtrate contained the complex, the free branched beta cyclodextrin and trace free hydrocortisone. This example was run at ambient conditions. Table 6 below further illustrates this example.
TABLE 6 Element Amount (gm )
Carbohydrate added 1.670
Free branched beta cyclodextrin added 1.635
Free branched beta cyclodextrin after complexation .489 Complexed branched beta cyclodextrin 1.146
Average molecular weight of branched beta cyclodextrin 4035
Average DP of branch 17.9
Hydrocortisone complexed in branched beta cyclodextrin .103
Free beta cyclodextrin added (impurity) --
Free beta cyclodextrin after complexation --
Complexed beta cyclodextrin --
Hydrocortisone complexed in beta cyclodextrin --
Free hydrocortisone added .150
Free soluble hydrocortisone after complexation .004 Table 6 ( continued)
Insoluble hydrocortisone after complexation .043
Complexation hydrocortisone (.107-.004) = .103
S/S0 (S= 107 = 9.39; S0 = .36 mg/ml ) 26.07 11.4
Water 10.3 ml
Solution 11.4 ml
Total Weight of Complex 1.249
Total Weight Hydrocortisone:Branched beta cyclodextrin 1.249
Total Weight Hydrocortisone: Beta cyclodextrin --
Efficiency (assume 1:1 complex)
1.146/1.635 .7009
The hydrocortisone was a commercially available hydrocortisone having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated. The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
The solubility of hydrocortisone in water under ambient conditions has been reported as 0.36 mg/ml. The observed solubility in water of the branched beta cyclodextrin and hydrocortisone complex in this example after concentration was 53.6 mg/ml under ambient conditions, By employing the present invention the solubility of the steroid has been increased by a factor of 149.
Example 7 This example illustrates preparation of a complex of branched beta cyclodextrin and steroid where the steroid is cholesterol.
A solution of branched beta cyclodextrin was prepared to about 14% solids by adding branched beta cyclodextrin to water in the amounts shown below in
Table 7. To this solution was added the cholesterol in the amounts shown in Table 7 below. The mixture was stirred for about 20 hours and then filtered to remove undissolved cholesterol. The filtrate contained the complex, the free branched beta cyclodextrin and trace free cholesterol. This example was run at ambient conditions. Table 7 below further illustrates this example. TABLE 7
Element Amount (gm)
Carbohydrate added 1.400
Free branched beta cyclodextrin added 1.202
Free branched beta cyclodextrin after complexation 1.037
Complexed branched beta cyclodextrin .165
Average molecular weight of branched beta cyclodextrin 1828
Average DP of branch 4.27 Cholesterol complexed in branched beta cyclodextrin .035
Free beta cyclodextrin added (impurity) --
Free beta cyclodextrin after complexation --
Complexed beta cyclodextrin -- Cholesterol complexed in beta cyclodextrin --
Free cholesterol added .300
Free soluble cholesterol after complexation .00002 Insoluble cholesterol after complexation .265
Complexation cholesterol (.035-.000) = .035
S/S0 (S= 35 = 3.68; S0 = .002 mg/ml ) 1838 9.52
Water 8.6 ml Table 7 (continued)
Solution 9.52 ml
Total Weight of Complex .200
Total Weight Cholesterol:Branched beta cyclodextrin .200
Total Weight Cholesterol:Beta cyclodextrin --
Efficiency .137
The cholesterol was a commercially available cholesterol having a high purity.
The amount of carbohydrate added, free steroid added, and water were measured using a conventional analytical balance. Chromatographic procedures were used to determine the percentages of branched beta cyclodextrin, beta cyclodextrin and other carbohydrates present in the carbohydrates added. The amount of insoluble steroid after complexation was determined by the difference between the dry weight of the filter paper before filtration and the dry weight of the filter paper after washing to remove excess carbohydrate and drying. The remaining values in the table above were calculated.
The branched beta cyclodextrin was obtained by solvent precipitation and chromatographic separation from a typical CGT digest of 5 DE waxy hydrolysate. The beta cyclodextrin and other carbohydrates which are not branched beta cyclodextrin are impurities which were not fully separated.
The solubility of cholesterol in water under ambient conditions has been reported as 0.002 mg/ml. The observed solubility in water of the branched beta cyclodextrin and cholesterol complex in this example was 3.7 mg/ml under ambient conditions. By employing the present invention the solubility of the steroid has been increased by a factor of 1838.
Example 8
This example compares the solubility of the branched beta cyclodextrin-steroid complex of the present invention against like steroids complexed with gamma cyclodextrin, alpha cyclodextrin, beta cyclodextrin, and dimethyl beta cyclodextrin. The gamma, alpha, and dimethyl beta cyclodextrin complexes were prepared under ambient conditions with cyclodextrins at a concentration of 0.075 M. Because of the low solubility of beta cyclodextrin, the concentration of this solution was 0.0112 M in water under ambient conditions. The results of this example are reported in Table 8 below. Table 8
Solubility (mg/ml)
Methyltestosterone(a) Testosterone(b) Progesterone Hydrocortisone
Present Invention 10.03(b) 10.32 20.66 (Example 4) (Example 3) (Example 1)
Dimethyl Beta Cyclodextrin 13.70(a) 13.00 20.30
Gamma
Cyclodextrin 1.40(a) 0.09 4.30
Alpha
Cyclodextrin 0.43(a) 0.27 3.80
Beta
Cyclodextrin 0.19(a) 0.09 1.82
Clearly the present invention produces superior results compared to the gamma and beta cyclodextrin and comparable results to dimethyl beta cyclodextrin.
The values of the dimethyl beta, gamma and alpha cyclodextrin steroid complex were taken from reported data.
The values of the present invention reported above were calculated from Examples 1, 3 and 4 above for comparative purposes. It will be understood that the preferred embodiments of the present invention herein chosen for the purpose of illustration are intended to cover all changes and modifications of the preferred embodiments of the present invention which do not constitute a departure from the spirit and scope of the present invention.

Claims

What is claimed is :
1. A water soluble compound formed by complexing branched beta cyclodextrin with a steroid having a molecular structure that can fit into the cavity of the branched beta cyclodextrin and form a complex with the branched beta cyclodextrin.
2. The water soluble compound of claim 1 wherein the steroid is selected from the group consisting of : corticosteroids, androgens, anabolic steroids, estrogens, and progestagens; that have a molecular structure that can fit into the cavity of the branched beta cyclodextrin and form a complex with the branched beta cyclodextrin.
3. The water soluble compound of claim 1 wherein the steroid is selected from the group consisting of: dexamethasone, prednisolone and cholesterol.
4. The water soluble compound of claim 1 wherein the branched beta cyclodextrin has a branch containing between about 1 glucose unit to about 7 glucose units.
5. The water soluble compound of claim 3 wherein the branched beta cyclodextrin has a branch containing between about 1 glucose unit to about 7 glucose units.
6. A method for increasing the solubility of a steroid comprising the steps of:
(a) forming an aqueous mixture of branched beta cyclodextrin and steroid in a stoichiometric ratio of about 1:1; and
(b) recovering a complex of branched beta cyclodextrin and steroid.
7. The method of claim 6 wherein the formation of the aqueous mixture of branched beta cyclodextrin and steroid is conducted under ambient conditions.
8. The method of claim 6 wherein the formation step is accomplished by adding branched beta cyclodextrin to water and then adding the steroid and mixing the branched beta cyclodextrin and steroid in water for a period of about 4 to about 24 hours under ambient conditions.
9. The method of claim 6 wherein the recovery step is accomplished by evaporation.
10. The method of claim 8 wherein the recovery step is accomplished by evaporation.
EP19890909972 1988-08-15 1989-08-14 Water soluble branched beta cyclodextrin steroid complex Ceased EP0381747A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23244088A 1988-08-15 1988-08-15
US232440 1988-08-15

Publications (2)

Publication Number Publication Date
EP0381747A1 EP0381747A1 (en) 1990-08-16
EP0381747A4 true EP0381747A4 (en) 1991-09-11

Family

ID=22873120

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890909972 Ceased EP0381747A4 (en) 1988-08-15 1989-08-14 Water soluble branched beta cyclodextrin steroid complex

Country Status (4)

Country Link
EP (1) EP0381747A4 (en)
JP (1) JPH0643314B2 (en)
HU (1) HU206366B (en)
WO (1) WO1990001320A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518930A4 (en) * 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
FR2667070A1 (en) * 1990-09-21 1992-03-27 Besins Iscovesco Labo STEROIDS INCLUDED IN CYCLODEXTRINS PROCESS FOR THEIR PREPARATION COMPLEXES AND CORRESPONDING GOLENIC FORMS AND THEIR THERAPEUTIC APPLICATIONS.
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co An aqueous nasal suspension comprising cyclodextrin
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
GB2482868A (en) 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327766A2 (en) * 1987-12-30 1989-08-16 University Of Florida Redox systems for brain-targeted drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609524B2 (en) * 1979-06-01 1985-03-11 理化学研究所 Cyclodextrin recovery method
DE3270055D1 (en) * 1981-01-23 1986-04-30 Wellcome Found Chemical complex
HU190356B (en) * 1981-10-27 1986-08-28 Richter Gedeon Vegyeszeti Termekek Gyara Rt,Hu Process for preparing steroid-gamma-cyclodextrin inclusion complexes with high water-solubility
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
JPS6192592A (en) * 1984-10-12 1986-05-10 Norin Suisansyo Shokuhin Sogo Kenkyusho Production of branched cyclodextrin
JPS62123196A (en) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd Prednisolone inclusion compound
JPH0635481B2 (en) * 1986-01-14 1994-05-11 日研化学株式会社 Diglucosyl-α-cyclodextrin and method for producing the same
JPS62281855A (en) * 1986-05-29 1987-12-07 Daikin Ind Ltd Inclusion compounds containing vitamins, vitamin derivatives, or hormones
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPS6327440A (en) * 1986-07-18 1988-02-05 Sanraku Inc Glucosylated branched cyclodextrin-containing composition
JPH0764884B2 (en) * 1986-11-27 1995-07-12 株式会社トクヤマ Cyclodextrin composition
US4840679A (en) * 1987-07-08 1989-06-20 American Maize-Products Company Purification and separation of branched beta-cyclodextrins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327766A2 (en) * 1987-12-30 1989-08-16 University Of Florida Redox systems for brain-targeted drug delivery

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI(L), abstract no. 88-073862, Derwent Publications Ltd, London, GB; & JP-A-63 027 440 (SANRAKU OCEAN) *
INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 49, no. 2, 15th January 1989, pages 163-171, Elsevier Science Publishers B.V. (Biomedical Division); M. YAMAMOTO et al.: "Some physicochemical properties of branched beta-cyclodextrins and their inclusion characteristics" *
See also references of WO9001320A1 *

Also Published As

Publication number Publication date
EP0381747A1 (en) 1990-08-16
HUT51287A (en) 1990-04-28
JPH0643314B2 (en) 1994-06-08
HU206366B (en) 1992-10-28
JPH02167228A (en) 1990-06-27
WO1990001320A1 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
US5229370A (en) Water soluble branched beta cyclodextrin steroid complex
US4668626A (en) Method for the preparation of branched cyclodextrins
US4384898A (en) Process for producing cyclodextrins
US4366308A (en) Process for the production of polysaccharide RBS substance
US4738923A (en) Process for producing and separating cyclodextrins
EP0389586B1 (en) Method for making branched cyclodextrins and product produced thereby
US4840679A (en) Purification and separation of branched beta-cyclodextrins
US3640847A (en) Procedure for production of alpha-cyclodextrin
EP0381747A4 (en) Water soluble branched beta cyclodextrin steroid complex
US6884885B2 (en) Production of cyclodextrin complexes
EP0607264B1 (en) Increased cyclodextrin production
US5658390A (en) Purification of beta cyclodextrin
US5032182A (en) Branched cyclodextrins
US5366879A (en) Method of preparing branched cyclodextrin
US5118354A (en) Method for making branched cyclodextrins and product produced thereby
KR0136363B1 (en) Method for preparing cyclodextrin
CA1293250C (en) Separation and purification of branched beta-cyclodextrins
JP2913017B2 (en) Method for producing cyclodextrins from starch granules
KR100192061B1 (en) Method of preparation of highly pure cyclodextrin
HUT71705A (en) Purification of beta cyclodextrin
JPH0333316B2 (en)
JPH0441998B2 (en)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB NL

A4 Supplementary search report drawn up and despatched

Effective date: 19910722

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB NL

17Q First examination report despatched

Effective date: 19920331

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19960219